Brivet-Chevillotte P, di Rago J P
Laboratoire de Chimie Bactérienne, CNRS, Marseille, France.
FEBS Lett. 1989 Sep 11;255(1):5-9. doi: 10.1016/0014-5793(89)81050-6.
The yeast box-mutant W7 exhibits deficiencies in cytochrome b and in nuclear coded complex III subunits, a phenotype observed previously in a patient with mitochondrial myopathy. DNA sequence analysis of mutant W7 revealed a single base transition in the cytochrome b gene; the mutated residue Gly 131 is perfectly conserved in all known cytochromes b and belongs to the Qo domain. Mutant W7 provides a model system for evaluating the action of therapeutic agents, such as vitamin K3 which restored NADH-oxidase activity in the mutant as well as in the antimycin-inhibited wild type. However, with the mutant, a greater quantity of menadione was necessary due to a decrease in other complex activities, and a much lower electron-flow fraction passed through cytochrome oxidase.
酵母盒式突变体W7在细胞色素b和核编码的复合物III亚基方面表现出缺陷,这种表型先前在一名线粒体肌病患者中观察到。对突变体W7的DNA序列分析揭示了细胞色素b基因中的一个单碱基转换;突变的残基甘氨酸131在所有已知的细胞色素b中完全保守,并且属于Qo结构域。突变体W7提供了一个用于评估治疗剂作用的模型系统,例如维生素K3,它能恢复突变体以及抗霉素抑制的野生型中的NADH氧化酶活性。然而,对于突变体,由于其他复合物活性的降低,需要更多量的甲萘醌,并且通过细胞色素氧化酶的电子流分数要低得多。